期刊文献+

单核样髓源性抑制细胞在炎症性肠病中的表达及其临床意义 被引量:1

Expression and Significance of Monocytic Myeloid-derived Suppressor Cells in Inflammatory Bowel Disease
下载PDF
导出
摘要 近年来炎症性肠病(IBD)发病率呈上升趋势,其病理生理学机制复杂且仍未明确。目的:研究单核样髓源性抑制细胞(MDSCs)在IBD患者外周血单核细胞中的比例,分析单核样MDSCs与IBD活动性的关系,从而初步探讨单核样MDSCs在IBD中的作用机制。方法:纳入IBD患者60例,分为克罗恩病(CD)组(n=33)和溃疡性结肠炎(UC)组(n=27),选取30名同期健康体检者作为正常对照组,采用流式细胞仪检测CD组、UC组、正常对照组患者外周血单核样MDSCs/单核细胞比例,分析单核样MDSCs与IBD患者WBC、PLT、ESR、CRP的相关性。结果:CD组和UC组外周血单核样MDSCs/单核细胞比例较正常对照组相比显著升高[(43.7±23.0)%、(49.1±27.2)%对(10.7±7.4)%](P<0.01),CD组与UC组相比差异无统计学意义(P>0.05)。活动期CD和UC组外周血单核样MDSCs/单核细胞比例均较缓解期组显著升高[(60.3±16.8)%、(66.3±17.6)%对(28.1±16.2)%、(19.9±9.0)%](P<0.01)。IBD患者外周血单核样MDSCs/单核细胞比例与WBC计数、PLT计数呈正相关(r=0.44,P=0.02;r=0.43,P=0.02),与ESR、CRP不相关(r=0.33,P=0.08;r=0.30,P=0.12)。结论:IBD患者外周血单核样MDSCs比例明显升高,与IBD活动性密切相关。单核样MDSCs在IBD发病中具有重要作用。 Background: The incidence of inflammatory bowel disease (IBD) was increasing recently. However, its pathologic mechanism is complicated and has not been fully clarified. Aims: To investigate the monocytic myeloid-derived suppressor cells (MDSCs) / monocyte ratio in peripheral blood of IBD patients, and analyze the relationship between monocytic MDSCs and the activity of IBD, so as to explore the role of monocytic MDSCs in the pathogenesis of IBD. Methods: A total of 60 patients with IBD were enrolled and assigned into Crohn' s disease (CD) group (n = 33) and ulcerative colitis (UC) group ( n = 27). Thirty healthy subjects were served as normal controls. The monocytic MDSCs / monocyte ratio in peripheral blood in CD, UC and normal control groups were detected by flow cytometry, and the correlations between monocytic MDSCs and WBC, PLT, ESR, CRP were analyzed. Results: Compared with normal control group, the monocytic MDSCs / monocyte ratio in peripheral blood increased significantly in CD and UC groups [ (43.7± 23.0) % , (49.1± 27.2)% vs. (10.7± 7.4)% ] (P 〈 0.01 ), and no significant difference was found between CD and UC groups (P 〉 0.05). The monocytic MDSCs / monocyte ratio in active stage CD and UC groups were significantly higher than those in remission stage groups [ (60.3 ± 16.8) %, (66.3 ± 17.6) % vs. (28.1 ± 16.2) %, ( 19.9 ± 9.0) % ] (P 〈 0.01 ) .A positive correlation was found between monocytic MDSCs / monocyte ratio and peripheral WBC, PLT count ( r = 0.44, P = 0.02; r = 0.43, P = 0.02), but no association was found between monocytic MDSCs/monocyte ratio and ESR, CRP (r = 0.33, P = 0.08 ; r = 0.30, P = 0.12). Conclusions : Monocytic MDSCs / monocyte ratio is increased markedly in IBD patients, which correlates closely to the activity of IBD, suggesting that monocytic MDSCs may play an important role in the pathogenesis of IBD.
出处 《胃肠病学》 2013年第3期139-142,共4页 Chinese Journal of Gastroenterology
基金 2011年度苏州市科教兴卫青年科技项目(KJXW2011001)资助
关键词 CROHN病 结肠炎 溃疡性 髓源性抑制细胞 流式细胞术 Crohn Disease Colitis, Ulcerative Myeloid-Derived Suppressor Cells Flow Cytometry
  • 相关文献

参考文献13

  • 1Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system[ J]. Nat Rev Immunol, 2009, 9 (3) : 162-174.
  • 2Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer [ J ]. J Immunol, 2009, 182 (8) : 4499-4506.
  • 3中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1020
  • 4Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4 (+) CD25 (+) Foxp3 (+) T cells [ J ]. Gastroenterology, 2008, 135 ( 1 ) : 234-243.
  • 5Wendelsdorf K, Bassaganya-Riera J, Hontecillas R, et al. Model of colonic inflammation : immune modulatory mechanisms in inflammatory bowel disease [ J ]. J Theor Biol, 2010, 264 (4) : 1225-1239.
  • 6Dharmani P, Chadee K. Biologic therapies against inflamrtkatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key [ J ]. Curr Mol Pharmacol, 2008, 1 (3) : 195-212.
  • 7Haile LA, von Wasielewski R, Gamrekelashvili J, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway [ J ]. Gastro- enterology, 2008, 135 (3) : 871-881.
  • 8Delano M J, Scumpia PO, Weinstein JS, et al. MyD88- dependent expansion of an immature GR-1 (+) CD1 lb (+) population induces T cell suppression and Th2 polarization in sepsis[J]. J Exp Med, 2007, 204 (6) : 1463-1474.
  • 9Dong L, Li J, Liu Y, et al. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifutobacteria in dextran sulfate sodium-induced colitis in mice [ J ]. J Gastroenterol Hepatol, 2012, 27 (1): 110-119.
  • 10Hang EH, Chang SY, Lee BR, et al. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells [ J ]. Int J Cancer, 2012 [ Epub ahead of print ].

二级参考文献15

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1019

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部